Okay, so there is an article about some health care stocks that might not be good to buy or hold in the first three months of this year. They are talking about three companies and why they think these companies may not do well. One way they measure this is by looking at something called the RSI, which helps them see how strong a company's stock price is compared to other times. If a company has an RSI above 70, it means that its stock price might be too high and could go down soon. The three companies mentioned in the article are Avidity Biosciences, Catalyst Pharmaceuticals, and another one. Read from source...

1. The article is misleading and lacks credibility by using outdated data (Feb 29, 2024). Why would you trust a source that doesn't update its information? It seems like the author wants to manipulate the readers with old numbers that may not reflect the current market situation.